Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia [PDF]
BMJ Open, 2022 Introduction Zambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city.
Victor M Mukonka +16 more
doaj +3 more sources
An overview of VaxchoraTM, a live attenuated oral cholera vaccine [PDF]
Human Vaccines & Immunotherapeutics, 2020 Cholera remains a public health threat among the least privileged populations and regions affected by conflicts and natural disasters. Together with Water, Sanitation and Hygiene practices, use of oral cholera vaccines (OCVs) is a key tool to prevent ...
Tarun Saluja +4 more
doaj +3 more sources
Journal of Travel Medicine, 2000 Cholera causes significant morbidity and mortality worldwide. For travelers, the risk of developing cholera per month of stay in a developing country is approximately 0.001%-0.01%, and cholera may present as traveler's diarrhea. In the United States, only a poorly tolerated, marginally effective, parenterally administered, phenol-inactivated vaccine is
Edward T. Ryan, Stephen B. Calderwood
openalex +6 more sources
Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis [PDF]
BMJ Global HealthIntroduction Millions of Euvichol-Plus doses have been deployed from the global oral cholera vaccine stockpile in over 20 cholera-affected countries. However, information on Euvichol-Plus’s effectiveness is limited.
Amanda Tiffany +20 more
doaj +2 more sources
Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. [PDF]
PLoS Neglected Tropical Diseases, 2012 Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine. Balancing this concern is the
Ramadhan Hashim +24 more
doaj +3 more sources
Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo [PDF]
Emerging Infectious DiseasesWe conducted 4 years of epidemiologic and genomic surveillance of single-dose effectiveness of a killed whole-cell oral cholera vaccine (kOCV) and Vibrio cholerae transmission in the Democratic Republic of the Congo.
Christine Marie George +14 more
doaj +2 more sources
Cholera Vaccine Workshop [PDF]
Journal of Infectious Diseases, 1994 R. Bradley Sack, M. John Albert
openalex +3 more sources
Assessment of Stability of Chemical Cholera Vaccine in a New Primary Packaging
Проблемы особо опасных инфекций, 2023 The bivalent chemical cholera vaccine is the only drug for the prevention of cholera registered in the Russian Federation. The vaccine has been produced in glass bottles containing 210 tablets.
O. V. Gromova +10 more
doaj +1 more source
Immunogenicity of cholera vaccination in children with inflammatory bowel disease
Human Vaccines & Immunotherapeutics, 2021 The cholera vaccine can protect patients with inflammatory bowel disease (IBD) against both cholera and travelers’ diarrhea. However, both immunosuppressive treatment and IBD can affect its vaccine immunogenicity.
Łukasz Dembiński +5 more
doaj +1 more source